Grown Rogue International Inc
CNSX:GRIN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Parker-Hannifin Corp
XBER:PAR
|
US |
|
B
|
Bergs Timber AB (publ)
STO:BRG B
|
SE |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (8.4), the stock would be worth CA$-0.13 (128% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -29.9 | CA$0.47 |
0%
|
| 3-Year Average | 8.4 | CA$-0.13 |
-128%
|
| 5-Year Average | 6.9 | CA$-0.11 |
-123%
|
| Industry Average | 7.9 | CA$-0.13 |
-127%
|
| Country Average | 10.2 | CA$-0.16 |
-134%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
G
|
Grown Rogue International Inc
CNSX:GRIN
|
117.3m CAD | -29.9 | 13.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 28.5 | 42.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
544.6B USD | 16.6 | 25.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 11.6 | 19.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
225.4B GBP | 16.2 | 29.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF | 12.4 | 20 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
278.5B USD | 9.6 | 15.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 386.8 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 8 | 10.8 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.3B USD | 7.6 | 19.6 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.4B USD | 7.1 | 16.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 7 |
| Median | 10.2 |
| 70th Percentile | 14.5 |
| Max | 13 731.1 |
Other Multiples
Grown Rogue International Inc
Glance View
Grown Rogue International, Inc. operates as a seed to experience cannabis brand. The company is headquartered in Toronto, Ontario. The company went IPO on 2016-11-18. The Company’s geographical segments include the United States and Canada. The firm is a vertically integrated cannabis brand that produces and distributes cannabis products. The firm's products include sungrown and indoor flowers, along with nitro-sealed indoor, and sungrown pre-rolls and jars.
